Copyright Reports & Markets. All rights reserved.

Global Hip Tendinitis Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Hip Tendinitis by Type
    • 1.3.1 Overview: Global Hip Tendinitis Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Hip Tendinitis Consumption Value Market Share by Type in 2025
    • 1.3.3 Internal Snapping Hip
    • 1.3.4 External Snapping Hip
    • 1.3.5 Intra-articular Snapping Hip
  • 1.4 Global Hip Tendinitis Market by Application
    • 1.4.1 Overview: Global Hip Tendinitis Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals & Clinics
    • 1.4.3 Medical Research Centers
    • 1.4.4 Academic Institutes
    • 1.4.5 Others
  • 1.5 Global Hip Tendinitis Market Size & Forecast
  • 1.6 Global Hip Tendinitis Market Size and Forecast by Region
    • 1.6.1 Global Hip Tendinitis Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Hip Tendinitis Market Size by Region, (2021-2032)
    • 1.6.3 North America Hip Tendinitis Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Hip Tendinitis Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Hip Tendinitis Market Size and Prospect (2021-2032)
    • 1.6.6 South America Hip Tendinitis Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Hip Tendinitis Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Almatica Pharma
    • 2.1.1 Almatica Pharma Details
    • 2.1.2 Almatica Pharma Major Business
    • 2.1.3 Almatica Pharma Hip Tendinitis Product and Solutions
    • 2.1.4 Almatica Pharma Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Almatica Pharma Recent Developments and Future Plans
  • 2.2 AstraZeneca
    • 2.2.1 AstraZeneca Details
    • 2.2.2 AstraZeneca Major Business
    • 2.2.3 AstraZeneca Hip Tendinitis Product and Solutions
    • 2.2.4 AstraZeneca Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 AstraZeneca Recent Developments and Future Plans
  • 2.3 Bayer
    • 2.3.1 Bayer Details
    • 2.3.2 Bayer Major Business
    • 2.3.3 Bayer Hip Tendinitis Product and Solutions
    • 2.3.4 Bayer Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Bayer Recent Developments and Future Plans
  • 2.4 Boehringer Ingelheim Pharmaceuticals
    • 2.4.1 Boehringer Ingelheim Pharmaceuticals Details
    • 2.4.2 Boehringer Ingelheim Pharmaceuticals Major Business
    • 2.4.3 Boehringer Ingelheim Pharmaceuticals Hip Tendinitis Product and Solutions
    • 2.4.4 Boehringer Ingelheim Pharmaceuticals Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Boehringer Ingelheim Pharmaceuticals Recent Developments and Future Plans
  • 2.5 Merck & Co.
    • 2.5.1 Merck & Co. Details
    • 2.5.2 Merck & Co. Major Business
    • 2.5.3 Merck & Co. Hip Tendinitis Product and Solutions
    • 2.5.4 Merck & Co. Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Merck & Co. Recent Developments and Future Plans
  • 2.6 Pfizer
    • 2.6.1 Pfizer Details
    • 2.6.2 Pfizer Major Business
    • 2.6.3 Pfizer Hip Tendinitis Product and Solutions
    • 2.6.4 Pfizer Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Pfizer Recent Developments and Future Plans
  • 2.7 Abbott
    • 2.7.1 Abbott Details
    • 2.7.2 Abbott Major Business
    • 2.7.3 Abbott Hip Tendinitis Product and Solutions
    • 2.7.4 Abbott Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Abbott Recent Developments and Future Plans
  • 2.8 GlaxoSmithKline
    • 2.8.1 GlaxoSmithKline Details
    • 2.8.2 GlaxoSmithKline Major Business
    • 2.8.3 GlaxoSmithKline Hip Tendinitis Product and Solutions
    • 2.8.4 GlaxoSmithKline Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.9 Teva Pharmaceuticals
    • 2.9.1 Teva Pharmaceuticals Details
    • 2.9.2 Teva Pharmaceuticals Major Business
    • 2.9.3 Teva Pharmaceuticals Hip Tendinitis Product and Solutions
    • 2.9.4 Teva Pharmaceuticals Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Teva Pharmaceuticals Recent Developments and Future Plans
  • 2.10 Lupin Pharmaceuticals
    • 2.10.1 Lupin Pharmaceuticals Details
    • 2.10.2 Lupin Pharmaceuticals Major Business
    • 2.10.3 Lupin Pharmaceuticals Hip Tendinitis Product and Solutions
    • 2.10.4 Lupin Pharmaceuticals Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Lupin Pharmaceuticals Recent Developments and Future Plans
  • 2.11 Geri-Care Pharmaceuticals
    • 2.11.1 Geri-Care Pharmaceuticals Details
    • 2.11.2 Geri-Care Pharmaceuticals Major Business
    • 2.11.3 Geri-Care Pharmaceuticals Hip Tendinitis Product and Solutions
    • 2.11.4 Geri-Care Pharmaceuticals Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Geri-Care Pharmaceuticals Recent Developments and Future Plans
  • 2.12 Perrigo Company
    • 2.12.1 Perrigo Company Details
    • 2.12.2 Perrigo Company Major Business
    • 2.12.3 Perrigo Company Hip Tendinitis Product and Solutions
    • 2.12.4 Perrigo Company Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Perrigo Company Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Hip Tendinitis Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Hip Tendinitis by Company Revenue
    • 3.2.2 Top 3 Hip Tendinitis Players Market Share in 2025
    • 3.2.3 Top 6 Hip Tendinitis Players Market Share in 2025
  • 3.3 Hip Tendinitis Market: Overall Company Footprint Analysis
    • 3.3.1 Hip Tendinitis Market: Region Footprint
    • 3.3.2 Hip Tendinitis Market: Company Product Type Footprint
    • 3.3.3 Hip Tendinitis Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Hip Tendinitis Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Hip Tendinitis Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Hip Tendinitis Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Hip Tendinitis Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Hip Tendinitis Consumption Value by Type (2021-2032)
  • 6.2 North America Hip Tendinitis Market Size by Application (2021-2032)
  • 6.3 North America Hip Tendinitis Market Size by Country
    • 6.3.1 North America Hip Tendinitis Consumption Value by Country (2021-2032)
    • 6.3.2 United States Hip Tendinitis Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Hip Tendinitis Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Hip Tendinitis Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Hip Tendinitis Consumption Value by Type (2021-2032)
  • 7.2 Europe Hip Tendinitis Consumption Value by Application (2021-2032)
  • 7.3 Europe Hip Tendinitis Market Size by Country
    • 7.3.1 Europe Hip Tendinitis Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Hip Tendinitis Market Size and Forecast (2021-2032)
    • 7.3.3 France Hip Tendinitis Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Hip Tendinitis Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Hip Tendinitis Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Hip Tendinitis Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Hip Tendinitis Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Hip Tendinitis Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Hip Tendinitis Market Size by Region
    • 8.3.1 Asia-Pacific Hip Tendinitis Consumption Value by Region (2021-2032)
    • 8.3.2 China Hip Tendinitis Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Hip Tendinitis Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Hip Tendinitis Market Size and Forecast (2021-2032)
    • 8.3.5 India Hip Tendinitis Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Hip Tendinitis Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Hip Tendinitis Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Hip Tendinitis Consumption Value by Type (2021-2032)
  • 9.2 South America Hip Tendinitis Consumption Value by Application (2021-2032)
  • 9.3 South America Hip Tendinitis Market Size by Country
    • 9.3.1 South America Hip Tendinitis Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Hip Tendinitis Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Hip Tendinitis Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Hip Tendinitis Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Hip Tendinitis Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Hip Tendinitis Market Size by Country
    • 10.3.1 Middle East & Africa Hip Tendinitis Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Hip Tendinitis Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Hip Tendinitis Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Hip Tendinitis Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Hip Tendinitis Market Drivers
  • 11.2 Hip Tendinitis Market Restraints
  • 11.3 Hip Tendinitis Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Hip Tendinitis Industry Chain
  • 12.2 Hip Tendinitis Upstream Analysis
  • 12.3 Hip Tendinitis Midstream Analysis
  • 12.4 Hip Tendinitis Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hip Tendinitis market size was valued at US$ 339 million in 2025 and is forecast to a readjusted size of US$ 473 million by 2032 with a CAGR of 4.9% during review period.
    Hip tendinitis is an uncomfortable inflammatory condition when a tendon in the hip becomes iritated or inflamed. Other names for it include hip tendonitis and hip flexor tendonitis. The rapidly increasing rate of the senior population worldwide and growing sports activities are primarily increasing the demand for hip tendonitis treatment.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Hip Tendinitis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Hip Tendinitis market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Hip Tendinitis market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Hip Tendinitis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Hip Tendinitis market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hip Tendinitis
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hip Tendinitis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Almatica Pharma, AstraZeneca, Bayer, Boehringer Ingelheim Pharmaceuticals, Merck & Co., Pfizer, Abbott, GlaxoSmithKline, Teva Pharmaceuticals, Lupin Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Hip Tendinitis market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Internal Snapping Hip
    External Snapping Hip
    Intra-articular Snapping Hip
    Market segment by Application
    Hospitals & Clinics
    Medical Research Centers
    Academic Institutes
    Others
    Market segment by players, this report covers
    Almatica Pharma
    AstraZeneca
    Bayer
    Boehringer Ingelheim Pharmaceuticals
    Merck & Co.
    Pfizer
    Abbott
    GlaxoSmithKline
    Teva Pharmaceuticals
    Lupin Pharmaceuticals
    Geri-Care Pharmaceuticals
    Perrigo Company
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Hip Tendinitis product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Hip Tendinitis, with revenue, gross margin, and global market share of Hip Tendinitis from 2021 to 2026.
    Chapter 3, the Hip Tendinitis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Hip Tendinitis market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Hip Tendinitis.
    Chapter 13, to describe Hip Tendinitis research findings and conclusion.

    Buy now